The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Proteome Profiling Services Market, 2020-2030

  • Lowest Price Guaranteed From USD 4,899

  • Published
    June 2020

  • Pages
    295

  • View Count
    656

Example Insights

Proteome-Profiling-Services-Market-Context 	Proteome-Profiling-Services-Market-Service-providers Proteome-Profiling-Services-Market-Various-applications
Proteome-Profiling-Services-Market-Geographical-Distribution Proteome-Profiling-Services-Market-Competitiveness-Analysis Proteome-Profiling-Services-Market-Partnerships-and-Collaborations
Proteome-Profiling-Services-Market-Key-Market Proteome-Profiling-Services-Market-Forecast  

 

Overview

Proteins are complex biomolecules that are involved in a number of essential functions in living organisms. Proteome profiling refers to the large-scale, high-throughput analysis of biological samples for the detection, identification, and functional characterization of resident proteins. The process includes the study of polypeptide structure, expression, function, protein-protein interactions, and post translational modifications (PTMs). With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive, and accurate quantification methods to analyze clinical specimens. As a result, proteome profiling has become an indispensable part of modern drug discovery and development process and disease diagnosis. It is worth highlighting that various types of proteomic analyses are being used in diagnosis, severity determination and therapy development efforts against COVID-19. In fact, one study reported the potential implications of the urinary proteome in understanding the pathophysiology of the disease.

Currently, the demand for proteome profiling is high, given the growing pipeline of peptide therapeutics. Although some pharmaceutical companies have invested in building in-house proteomics research capabilities, significant capital investments and specialized requirements renders this approach prohibitive for most stakeholders. This has created a demand for service provider companies with expertise in this field. In fact, since 2000, more than 85 players offering proteome profiling services have been incorporated. Amidst growing competition in the proteome profiling services market, availability of cutting-edge tools and the latest analytical serves to differentiate the offerings of stakeholders in this upcoming industry. Consequently, several service providers have actively begun expanding their respective service portfolios, either through strategic acquisitions or entering into service alliances with other specialty companies. Over time, several players have developed end-to-end capabilities, ranging from sample preparation to in silico analysis and post translational modifications-related expertise. As a consequence, the contract services market catering to this segment of the pharmaceutical industry, is anticipated to witness substantial growth in the coming years.

Scope of the Report

The ‘Proteome Profiling Services Market, 2020-2030’ report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:

  • A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider (industry and non-industry), year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling (protein identification, protein quantification, protein separation, protein extraction and protein purification), service(s) offered for proteome profiling (analysis of post translational modifications, protein characterization, in silico analysis and protein sequencing), other service(s) offered (protein-protein interaction analysis, biomarker discovery, biological pathway identification, impurity profile analysis, bio imaging of proteins), type of product profiled (proteins and peptides), type of sample(s) used (cells, tissues, plasma, serum, urine, cerebrospinal fluid (d), blood, saliva, cyst fluid and others) and type of application (drug discovery, disease diagnosis and others).
  • Elaborate profiles of the prominent players (shortlisted based on a proprietary criterion) across North America, Europe and Asia Pacific and rest of the world. Each profile includes a brief overview of the company, its year of establishment, location of headquarters, number of employees and financial information (if available). In addition to this, the profile includes information on the proteome profiling services offered by the company, along with information on the proteome profiling technologies used. Further, we have provided the recent developments of the company and an informed future outlook. 
  • A competitiveness analysis of proteome profiling service providers, taking into consideration the supplier strength (based on company size and its experience in this field), service strength (based on number of pre-proteome profiling service(s) offered, number of proteome profiling service(s) offered, number of other service(s) offered, number of product types profiled and number of applications) and number of samples profiled (which is depicted by size of the bubble).
  • An analysis of the partnerships that have been inked by stakeholders in the proteome profiling services domain, during the time period 2014-2020 (till April), covering different partnership models, such as service alliances, acquisitions, technology licensing, R&D agreements and research agreements.
  • An elaborate discussion on various factors contributing to the high price of proteome profiling. It features different pricing models of proteome profiling services based on number of proteins / samples processed, proteome profiling steps and sample types.
  • A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution, under a comprehensive SWOT framework; it includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry.
  • A detailed review of the impact of the COVID-19 pandemic on the overall proteome profiling services market. In addition, it features various strategies that different companies have adopted / might adopt in order to mitigate the challenges affiliated to the current global crisis.

One of the key objectives of the report was to estimate the existing market size and the future growth potential of the proteome profiling services. Based on multiple parameters, such as projected growth of the overall proteomics market and extend of outsourcing, we have developed informed estimates on the financial evolution of the market, over the period 2020-2030. The report also provides details on the likely distribution of the current and forecasted opportunity across [A] type of application (drug discovery, disease diagnosis and others) [B] type of sponsor (pharmaceutical companies, research and academics institutes and CROs) [C] key geographical regions (North America, Europe, Asia Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth. 

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:

  • James Fedrick, President and Chief Executive Officer, Rockland Immunochemicals
  • Anton IIliuk, Chief technology Officer, Tymora Analytical Operations

Key Questions Answered

  • Who are the leading proteome profiling service providers?
  • What kind of partnership models are presently being used by stakeholders in this industry?
  • What is the impact of COVID-19 on the demand for proteome profiling services?
  • What factors are likely to influence the evolution of this upcoming market?
  • How is the current and future opportunity likely to be distributed across key market segments?

Contents

Chapter Outlines

Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of the proteome profiling services market and its likely evolution in the short-mid term and long term.

Chapter 3 provides a general introduction to proteome profiling services, featuring detailed description on various proteome profiling steps, the different types of proteome profiling technologies (conventional and advanced), various proteome profiling applications and the key challenges associated with profiling proteins. Additionally, it provides details related to the growing need for outsourcing of such services.

Chapter 4 provides an overview of the proteome profiling services market landscape. It features an in-depth analysis of over 210 players that claim to offer proteome profiling services, based on a number of parameters, such as type of service provider (industry and non-industry), year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling (protein identification, protein quantification, protein separation, protein extraction and protein purification), service(s) offered for proteome profiling (analysis of post translational modifications, protein characterization, in silico analysis and protein sequencing), other service(s) offered (protein-protein interaction analysis, biomarker discovery, biological pathway identification, impurity profile analysis, bio imaging of proteins), type of product profiled (proteins and peptides), type of sample(s) used (cells, tissues, plasma, serum, urine, CSF, blood, saliva, cyst fluid and others) and type of application (drug discovery, disease diagnosis and others).

Chapter 5 provides detailed profiles of players that are actively involved in the proteome profiling services market in North America. Each profile includes a brief overview of the company, its year of establishment, location of headquarters, number of employees and financial information (if available). In addition to this, the profile includes information on the proteome profiling services offered by the company, along with information on the proteome profiling technologies used. Further, we have provided the recent developments of the company and an informed future outlook. 

Chapter 6 provides detailed profiles of the key players that are active in the proteome profiling services market in Europe. Each profile includes a brief overview of the company, its year of establishment, location of headquarters, number of employees and financial information (if available). In addition to this, the profile includes information on the proteome profiling services offered by the company, along with information on the proteome profiling technologies used. Further, we have provided the recent developments of the company and an informed future outlook. 

Chapter 7 provides detailed profiles of the key players that are active in the proteome profiling services market in Asia Pacific and rest of the world. Each profile includes a brief overview of the company, its year of establishment, location of headquarters, number of employees and financial information (if available). In addition to this, the profile includes information on the proteome profiling services offered by the company, along with information on the proteome profiling technologies used. Further, we have provided the recent developments of the company and an informed future outlook. 

Chapter 8 features a competitiveness analysis of proteome profiling service providers, taking into consideration supplier strength (based on company size and its experience in this field), service strength (based on number of pre-proteome profiling service(s) offered, number of proteome profiling service(s) offered, number of other service(s) offered, number of product types profiled and number of applications) and number of samples profiled (which is depicted by size of the bubble).

Chapter 9 features an analysis of the various partnerships and collaborations that have been inked amongst players in this domain, in the time period 2014-2020 (till April). It provides a brief description on the various types of partnership models (which include service alliances, acquisitions, technology licensing, R&D agreements and research agreements) that have been adopted by stakeholders in this domain. Further, it includes analyses based on year of partnership, type of partnership, type of service mentioned in the agreement, type of application mentioned in the agreement and most active players. Furthermore, we have provided a world map representation of all the deals inked in this field, highlighting those that have been established within and across different continents.

Chapter 10 features an elaborate discussion on various factors contributing to the high price of proteome profiling. It features different pricing models of proteome profiling services based on number of proteins / samples processed, proteome profiling steps and sample types.

Chapter 11 provides a discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution, under a comprehensive SWOT framework. In addition, it includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry. 

Chapter 12 presents an insightful market forecast analysis, highlighting the likely growth of the proteome profiling services market till the year 2030. In order to provide details on the future opportunity, our projections have been segmented on the basis of [A] type of application (drug discovery, disease diagnosis and others) [B] type of sponsor (pharmaceutical companies, research and academics institutes and CROs) [C] key geographical regions (North America, Europe, Asia Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth. 

Chapter 13 highlights the impact of the COVID-19 pandemic on the overall proteome profiling services market. In addition, it features various strategies that different companies have adopted / might adopt in order to mitigate the challenges affiliated to the current global crisis.

Chapter 14 is a summary of the overall report, wherein we have mentioned all the key facts and figures described in the previous chapters. The chapter also highlights important evolutionary trends that were identified during the course of the study and are expected to influence the future of the proteome profiling services market.

Chapter 15 is a collection of interview transcripts of the discussions held with key stakeholders in the industry. We have presented details of interviews held with James Fedrick (President and Chief Executive Officer, Rockland Immunochemicals) and Anton IIliuk, (Chief technology Officer, Tymora Analytical Operations)

Chapter 16 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 17 is an appendix, which contains the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Proteome Profiling
3.2.1. Proteome Profiling Process
3.2.1.1. Protein Extraction, Separation and Purification
3.2.1.2. Protein Characterization
3.2.1.3. Protein Sequencing
3.2.1.4. Protein Quantification
3.2.1.5. In silico Analysis
3.2.1.6. Analysis of Post Translational Modifications
3.2.2. Proteome Profiling Technologies
3.2.2.1. Type of Proteome Profiling Technologies

3.2.3. Applications of Proteome Profiling
3.2.3.1. Biomarker Discovery
3.2.3.2. Disease Diagnosis
3.2.3.3. Drug Discovery
3.2.3.4. Elucidation of Cause / Propagation of Diseases
3.2.3.5. Toxicoproteomic Studies

3.2.4. Challenges Associated with Proteome Profiling
3.2.5. Outsourcing of Proteome Profiling 
3.2.6. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Proteome Profiling Service Providers: Overall Market Landscape
4.2.1. Analysis by Type of Service Provider
4.2.2. Analysis by Year of Establishment
4.2.3. Analysis by Company Size
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Type of Service(s) Offered
4.2.5.1. Analysis by Service(s) Offered for Pre-Proteome Profiling
4.2.5.2. Analysis by Service(s) Offered for Proteome Profiling
4.2.5.3. Analysis by Other Service(s) Offered
4.2.6. Analysis by Type of Product Profiled
4.2.7. Analysis by Type of Sample(s) Used
4.2.8. Analysis by Type of Application

5. COMPANY PROFILES: PROTEOME PROFILING SERVICE PROVIDERS IN NORTH AMERICA
5.1. Chapter Overview
5.2. Bioproximity
5.2.1. Company Overview
5.2.2. Proteome Profiling-related Service Offerings
5.2.3. Proteome Profiling Technology
5.2.4. Recent Developments and Future Outlook

5.3. Cell Signaling Technology
5.3.1. Company Overview
5.3.2. Proteome Profiling-related Service Offerings
5.3.3. Proteome Profiling Technology
5.3.4. Recent Developments and Future Outlook

5.4. Creative Biolabs
5.4.1. Company Overview
5.4.2. Proteome Profiling-related Service Offerings
5.4.3. Proteome Profiling Technology
5.4.4. Recent Developments and Future Outlook

5.5. Creative Proteomics
5.5.1. Company Overview
5.5.2. Proteome Profiling-related Service Offerings
5.5.3. Proteome Profiling Technology
5.5.4. Recent Developments and Future Outlook

5.6. Poochon Scientific
5.6.1. Company Overview
5.6.2. Proteome Profiling-related Service Offerings
5.6.3. Proteome Profiling Technology
5.6.4. Recent Developments and Future Outlook

6. COMPANY PROFILES: PROTEOME PROFILING SERVICE PROVIDERS IN EUROPE
6.1. Chapter Overview
6.2. Biognosys
6.2.1. Company Overview
6.2.2. Proteome Profiling-related Service Offerings
6.2.3. Proteome Profiling Technology
6.2.4. Recent Developments and Future Outlook

6.3. NMI TT Pharmaservices
6.3.1. Company Overview
6.3.2. Proteome Profiling-related Service Offerings
6.3.3. Proteome Profiling Technology
6.3.4. Recent Developments and Future Outlook

6.4. Proteome Factory
6.4.1. Company Overview
6.4.2. Proteome Profiling-related Service Offerings
6.4.3. Proteome Profiling Technology
6.4.4. Recent Developments and Future Outlook

6.5. Sciomics
6.5.1. Company Overview
6.5.2. Proteome Profiling-related Service Offerings
6.5.3. Proteome Profiling Technology
6.5.4. Recent Developments and Future Outlook

6.6. tebu-bio
6.6.1. Company Overview
6.6.2. Proteome Profiling-related Service Offerings
6.6.3. Proteome Profiling Technology
6.6.4. Recent Developments and Future Outlook

7. COMPANY PROFILES: PROTEOME PROFILING SERVICE PROVIDERS IN ASIA PACIFIC AND REST OF THE WORLD:
7.1. Chapter Overview
7.2. BGI
7.2.1. Company Overview
7.2.2. Proteome Profiling-related Service Offerings
7.2.3. Proteome Profiling Technology
7.2.4. Recent Developments and Future Outlook

7.3. Cytomics
7.3.1. Company Overview
7.3.2. Proteome Profiling-related Service Offerings
7.3.3. Proteome Profiling Technology
7.3.4. Recent Developments and Future Outlook

7.4. i-DNA Bioechnology
7.4.1. Company Overview
7.4.2. Proteome Profiling-related Service Offerings
7.4.3. Proteome Profiling Technology
7.4.4. Recent Developments and Future Outlook

7.5. Proteomics International
7.5.1. Company Overview
7.5.2. Proteome Profiling-related Service Offerings
7.5.3. Proteome Profiling Technology
7.5.4. Recent Developments and Future Outlook
7.6. VProteomics
7.6.1. Company Overview
7.6.2. Proteome Profiling-related Service Offerings
7.6.3. Proteome Profiling Technology
7.6.4. Recent Developments and Future Outlook

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Competitiveness Analysis: Industry Players
8.4.1. Competitiveness Analysis: Industry Players based in North America
8.4.2. Competitiveness Analysis: Industry Players based in Europe
8.4.3. Competitiveness Analysis: Industry Players based in Asia Pacific and Rest of the World

8.5. Competitiveness Analysis: Non-Industry Players
8.5.1. Competitiveness Analysis: Non-Industry Players based in North America
8.5.2. Competitiveness Analysis: Non-Industry Players in Europe
8.5.3. Competitiveness Analysis: Non-Industry Players based in Asia Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Proteome Profiling Services Providers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Service Mentioned in the Agreement
9.3.5. Analysis by Type of Application Mentioned in the Agreement
9.3.6. Most Active Players: Analysis by Number of Partnerships
9.3.7. Geographical Analysis
9.3.7.1. Region-wise Distribution
9.3.7.2. Country-wise Distribution

10. COST PRICE ANALYSIS
10.1. Chapter Overview
10.2. Factors Contributing to the High Price of Proteome Profiling
10.3. Price of Proteome Profiling
10.3.1. Pricing Based on Number of Proteins / Samples Processed
10.3.2. Pricing Based on Proteome Profiling Steps
10.3.3. Pricing Based on Sample Type

11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats
11.6. Concluding Remarks

12. MARKET SIZING AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Assumptions
12.3. Overall Proteome Profiling Services Market, 2020-2030
12.3.1. Proteome Profiling Services Market, 2020-2030: Distribution by Type of Application
12.3.2. Proteome Profiling Services Market, 2020-2030: Distribution by Type of Sponsor
12.3.3. Proteome Profiling Services Market, 2020-2030: Geographical Distribution
12.3.4. Proteome Profiling Services Market in North America, 2020-2030
12.3.5. Proteome Profiling Services Market in Europe, 2020-2030
12.3.6. Proteome Profiling Services Market in Asia Pacific, 2020-2030
12.3.7. Proteome Profiling Services Market in Rest of the World, 2020-2030

13. IMPACT OF THE COVID-19 PANDEMIC ON PROTEOME PROFILING SERVICES MARKET
13.1. Chapter Overview
13.2. Current Opinions and Recuperative Initiatives of Key Players
13.3. Impact on Future Market Opportunity for Proteome Profiling Services Market

14. CONCLUDING REMARKS
14.1. Chapter Overview
14.2. Key Takeaways

15. EXECUTIVE INSIGHTS
15.1. Chapter Overview

15.2. Rockland Immunochemicals
15.2.1. Company Snapshot
15.2.2. Interview Transcript: James Fedrick, President and Chief Executive Officer

15.3. Tymora Analytical Operation
15.3.1. Company Snapshot
15.3.2. Interview Transcript: Anton Iliuk, Vice President and Chief Technology Officer

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Proteome Profiling Process
Figure 3.2 Technologies used in Proteome Profiling
Figure 3.3 Proteome Profiling Applications
Figure 3.4 Challenges Associated with Proteome Profiling
Figure 4.1 Proteome Profiling Service Providers: Distribution by Type of Service Provider
Figure 4.2 Proteome Profiling Service Providers: Distribution by Year of Establishment
Figure 4.3 Proteome Profiling Service Providers: Distribution by Company Size
Figure 4.4 Proteome Profiling Service Providers: Distribution by Location of Headquarters
Figure 4.5 Proteome Profiling Service Providers: Distribution by Type of Service(s) Offered for Pre-Proteome Profiling
Figure 4.6 Proteome Profiling Service Providers: Distribution by Type of Service(s) Offered for Proteome Profiling
Figure 4.7 Proteome Profiling Service Providers: Distribution by Type of Other Service(s) Offered
Figure 4.8 Proteome Profiling Service Providers: Distribution by Type of Product Profiled
Figure 4.9 Proteome Profiling Service Providers: Distribution by Type of Sample(s) Used
Figure 4.10 Proteome Profiling Service Providers: Distribution by Type of Application
Figure 8.1 Company Competitiveness Analysis: Industry Players based in North America
Figure 8.2 Company Competitiveness Analysis: Industry Players based in Europe
Figure 8.3 Company Competitiveness Analysis: Industry Players based in Asia Pacific and Rest of the World
Figure 8.4 Company Competitiveness Analysis: Non-Industry Players based in North America
Figure 8.5 Company Competitiveness Analysis: Non-Industry Players based in Europe
Figure 8.6 Company Competitiveness Analysis: Non-Industry Players based in Asia Pacific and Rest of the World
Figure 9.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Service Mentioned in the Agreement
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Application Mentioned in the Agreement
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Application Mentioned in the Agreement and Type of Partnership
Figure 9.7 Most Active Players: Distribution by Number of Partnerships
Figure 9.8 Partnerships and Collaborations: Region-wise Distribution
Figure 9.9 Partnerships and Collaborations: Country-wise Distribution
Figure 11.1 Proteome Profiling Services: SWOT Analysis
Figure 11.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 12.1 Overall Proteome Profiling Services Market, 2020-2020 (USD Billion)
Figure 12.2 Proteome Profiling Services Market: Distribution by Type of Applications, 2020-2030 (USD Billion)
Figure 12.3 Proteome Profiling Services Market: Distribution by Type of Sponsor, 2020-2030 (USD Billion)
Figure 12.4 Proteome Profiling Services Market: Distribution by Key Geographical Regions, 2020 and 2030 (%)
Figure 12.5 Proteome Profiling Services Market in North America, 2020-2030 (USD Billion)
Figure 12.6 Proteome Profiling Services Market in Europe, 2020-2030 (USD Billion)
Figure 12.7 Proteome Profiling Services Market in Asia Pacific, 2020-2030 (USD Billion)
Figure 12.8 Proteome Profiling Services Market in Rest of the World, 2020-2030 (USD Billion)
Figure 13.1 Proteome Profiling Services Market, 2020-2030: COVID Impact Scenario (USD Billion)

List Of Tables

Table 3.1 Proteome Profiling Technologies
Table 4.1 Proteome Profiling Service Providers: List of Service Providers
Table 4.2 Proteome Profiling Service Providers: Information on Type of Service(s) Offered
Table 4.3 Proteome Profiling Service Providers: Information on Type of Sample(s) Used and Type of Application
Table 5.1 Leading Proteome Profiling Service Providers in North America
Table 5.2 Bioproximity: Company Overview
Table 5.3 Bioproximity: Proteome Profiling-related Service Offerings
Table 5.4 Bioproximity: Proteome Profiling Technologies
Table 5.5 Bioproximity: Recent Developments and Future Outlook
Table 5.6 Cell Signaling Technology: Company Overview
Table 5.7 Cell Signaling Technology: Proteome Profiling-related Service Offerings
Table 5.8 Cell Signaling Technology: Proteome Profiling Technologies
Table 5.9 Cell Signaling Technology: Recent Developments and Future Outlook
Table 5.10 Creative Biolabs: Company Overview
Table 5.11 Creative Biolabs: Proteome Profiling-related Service Offerings
Table 5.12 Creative Biolabs: Proteome Profiling Technologies
Table 5.13 Creative Biolabs: Recent Developments and Future Outlook
Table 5.14 Creative Proteomics: Company Overview
Table 5.15 Creative Proteomics: Proteome Profiling-related Service Offerings
Table 5.16 Creative Proteomics: Proteome Profiling Technologies
Table 5.17 Creative Proteomics: Recent Developments and Future Outlook
Table 5.18 Poochon Scientific: Company Overview
Table 5.19 Poochon Scientific: Proteome Profiling-related Service Offerings
Table 5.20 Poochon Scientific: Proteome Profiling Technologies
Table 5.21 Poochon Scientific: Recent Developments and Future Outlook
Table 6.1 Leading Proteome Profiling Service Providers in Europe
Table 6.2 Biognosys: Company Overview
Table 6.3 Biognosys: Proteome Profiling-related Service Offerings
Table 6.4 Biognosys: Proteome Profiling Technologies
Table 6.5 Biognosys: Recent Developments and Future Outlook
Table 6.6 NMI TT Pharmaservices: Company Overview
Table 6.7 NMI TT Pharmaservices: Proteome Profiling-related Service Offerings
Table 6.8 NMI TT Pharmaservices: Proteome Profiling Technologies
Table 6.9 NMI TT Pharmaservices: Recent Developments and Future Outlook
Table 6.10 Proteome Factory: Company Overview
Table 6.11 Proteome Factory: Proteome Profiling-related Service Offerings
Table 6.12 Proteome Factory: Proteome Profiling Technologies
Table 6.13 Proteome Factory: Recent Developments and Future Outlook
Table 6.14 Sciomics: Company Overview
Table 6.15 Sciomics: Proteome Profiling-related Service Offerings
Table 6.16 Sciomics: Proteome Profiling Technologies
Table 6.17 Sciomics: Recent Developments and Future Outlook
Table 6.18 tebu-bio: Company Overview
Table 6.19 tebu-bio: Proteome Profiling-related Service Offerings
Table 6.20 tebu-bio: Proteome Profiling Technologies
Table 6.21 tebu-bio: Recent Developments and Future Outlook
Table 7.1 Leading Proteome Profiling Service Providers in Asia Pacific and Rest of the World
Table 7.2 BGI: Company Overview
Table 7.3 BGI: Proteome Profiling-related Service Offerings
Table 7.4 BGI: Proteome Profiling Technologies
Table 7.5 BGI: Recent Developments and Future Outlook
Table 7.6 Cytomics: Company Overview
Table 7.7 Cytomics: Proteome Profiling-related Service Offerings
Table 7.8 Cytomics: Proteome Profiling Technologies
Table 7.9 Cytomics: Recent Developments and Future Outlook
Table 7.10 i-DNA Bioechnology: Company Overview
Table 7.11 i-DNA Bioechnology: Proteome Profiling-related Service Offerings
Table 7.12 i-DNA Bioechnology: Proteome Profiling Technologies
Table 7.13 i-DNA Bioechnology: Recent Developments and Future Outlook
Table 7.14 Proteomics International: Company Overview
Table 7.15 Proteomics International: Proteome Profiling-related Service Offerings
Table 7.16 Proteomics International: Proteome Profiling Technologies
Table 7.17 Proteomics International: Recent Developments and Future Outlook
Table 7.18 VProteomics: Company Overview
Table 7.19 VProteomics: Proteome Profiling-related Service Offerings
Table 7.20 VProteomics: Proteome Profiling Technologies
Table 7.21 VProteomics: Recent Developments and Future Outlook
Table 9.1 Proteome Profiling Service Providers: List of Partnerships, 2014-2020
Table 10.1 Proteome Profiling Services: Pricing based on Number of Proteins
Table 10.2 Proteome Profiling Services: Pricing based on Number of Samples
Table 10.3 Proteome Profiling Services: Pricing based on Proteome Profiling Steps
Table 10.4 Proteome Profiling Services: Pricing based on Sample Type
Table 14.1 Proteome Profiling Services: Summary of the Report
Table 15.1 Rockland Immunochemicals: Company Snapshot
Table 15.2 Tymora Analytical Operations: Company Snapshot
Table 16.1 Proteome Profiling Service Providers: Distribution by Type of Service Provider
Table 16.2 Proteome Profiling Service Providers: Distribution by Year of Establishment
Table 16.3 Proteome Profiling Service Providers: Distribution by Company Size
Table 16.4 Proteome Profiling Service Providers: Distribution by Location of Headquarters
Table 16.5 Proteome Profiling Service Providers: Distribution by Type of Service(s) Offered for Pre-Proteome Profiling
Table 16.6 Proteome Profiling Service Providers: Distribution by Type of Service(s) Offered for Proteome Profiling
Table 16.7 Proteome Profiling Service Providers: Distribution by Type of Other Service(s) Offered
Table 16.8 Proteome Profiling Service Providers: Distribution by Type of Product Profiled
Table 16.9 Proteome Profiling Service Providers: Distribution by Type of Sample(s) Used
Table 16.10 Proteome Profiling Service Providers: Distribution by Type of Application
Table 16.11 Partnerships and Collaborations: Distribution by Year of Partnership
Table 16.12 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.13 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 16.14 Partnerships and Collaborations: Distribution by Type of Service Mentioned in the Agreement
Table 16.15 Partnerships and Collaborations: Distribution by Type of Application Mentioned in the Agreement
Table 16.16 Partnerships and Collaborations: Distribution by Type of Application Mentioned in the Agreement and Type of Partnership
Table 16.17 Most Active Players: Distribution by Number of Partnerships
Table 16.18 Partnerships and Collaborations: Region-wise Distribution
Table 16.19 Partnerships and Collaborations: Country-wise Distribution
Table 16.20 Overall Proteome Profiling Services Market, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 16.21 Proteome Profiling Services Market: Distribution by Type of Applications, 2020-2030 (USD Billion)
Table 16.22 Proteome Profiling Services Market: Distribution by Type of Sponsor (USD Billion), 2020-2030
Table 16.23 Proteome Profiling Services Market: Distribution by Key Geographical Regions, 2020 and 2030 (%)
Table 16.24 Proteome Profiling Services Market in North America, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 16.25 Proteome Profiling Services Market in Europe, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 16.26 Proteome Profiling Services Market in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 16.27 Proteome Profiling Services Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2020-2030 (USD Billion)
Table 16.28 Proteome Profiling Services Market, 2020-2030: COVID Impact Scenario (USD Billion)

Listed Companies

The following companies and organizations have been mentioned in the report.

  1. Abzena
  2. Advanced Biomart
  3. Agilent Technologies
  4. Alphalyse
  5. Applied Biomics
  6. ARVYS Proteins
  7. Autonomous University of Barcelona
  8. AVMBioMed
  9. AxisPharm
  10. Baylor College of Medicine
  11. Beth Israel Deaconess Medical Center
  12. BGI
  13. BioAnalytix
  14. Biognosys
  15. BioMediTech
  16. BioPharmaSpec
  17. Bioproximity
  18. BioResource Biotech 
  19. Bio-Synthesis
  20. BIOTOOLS
  21. BioXpedia
  22. Boston Analytical
  23. Bruker
  24. Buck Institute for Research on Aging
  25. Caprion Biosciences
  26. Cedars-Sinai 
  27. Cell Signaling Technology 
  28. Center for Cooperative Research in Biosciences 
  29. Central European Institute of Technology
  30. Centre for Cellular and Molecular Biology
  31. Centre for Cellular And Molecular Platforms 
  32. Centre for Proteomic and Genomic Research
  33. Centre for Omic Sciences  
  34. Charité-Universitätsmedizin Berlin
  35. Chemily Glycoscience
  36. Cleveland Clinic Lerner Research Institute
  37. Cogentech
  38. Columbia University
  39. Cornell University
  40. CPR Pharma Services 
  41. Creative Bioarray
  42. Creative Proteomics
  43. Cytomics
  44. Dana-Farber Cancer Institute 
  45. David H. Koch Institute for Integrative Cancer Research
  46. DC Biosciences
  47. Dualsystems Biotech
  48. Duke Center for Genomic and Computational Biology 
  49. EirGenix
  50. Emory University
  51. European Molecular Biology Laboratory 
  52. First BASE Laboratories
  53. Focus Proteomics
  54. Fred Hutchinson Cancer Research Center
  55. Full Moon BioSystems
  56. Functional Genomics Center Zurich
  57. Genei Laboratories
  58. Genentech
  59. GenScript
  60. GenxbiO Health Sciences
  61. GHO Capital
  62. Gustave Roussy
  63. Haematologic Technologies
  64. Harvard University
  65. HistoGeneX
  66. HT-Labs
  67. IDeA National Resource for Quantitative Proteomics
  68. i-DNA Biotechnology
  69. Indian Institute of Technology, Madras
  70. Indiana University School of Medicine
  71. Indivumed
  72. Institute of Molecular Biology 
  73. Institut Curie 
  74. Institute of Bioinformatics 
  75. Institute for Research in Immunology and Cancer
  76. Instiut Pasteur
  77. Intertek
  78. ISAS
  79. ITSI-BIOSCIENCES
  80. JadeBio
  81. Janssen
  82. Jewish General Hospital
  83. John Innes Centre
  84. JPT Peptide Technologies
  85. Karolinska Institutet
  86. Keck School of Medicine of USC
  87. Kinexus
  88. Leadgene Biomedical
  89. Leibniz Institute on Aging - Fritz Lipmann Institute
  90. LI-COR Biosciences
  91. Ludwig Maximilian University of Munich
  92. Lynx Biosciences
  93. Macquarie University
  94. MatTek
  95. Max Perutz Labs
  96. Max Planck Institute
  97. Max Planck Institute of Biochemistry
  98. Max Planck Institute of Molecular Cell Biology and Genetics
  99. Mayo Clinic
  100. MD Anderson Cancer Center
  101. Medical University of South Carolina
  102. Medicines Discovery Catapult
  103. Medigene
  104. MELISA Institute
  105. Memorial Sloan Kettering Cancer Center 
  106. Monash University
  107. Montreal Clinical Research Institute 
  108. Moredun Research Institute
  109. Morehouse School of Medicine
  110. MS Bioworks
  111. MtoZ Biolabs
  112. NanoString Technologies
  113. Nanoxis Consulting
  114. National Cancer Institute
  115. National Resource for Translational and Developmental Proteomics
  116. N-Cell Technology
  117. NEC Solution Innovators
  118. Neuro-Sys
  119. Nexelis
  120. NH DyeAGNOSTICS 
  121. NMI TT Pharmaservices
  122. Norwegian University of Science and Technology
  123. NovaBioAssays
  124. Novartis
  125. Novatia
  126. Nucro-Technics
  127. Ocean Ridge Biosciences
  128. Ohio State University
  129. Oregon Health & Science University
  130. Ospedale San Raffaele
  131. Parker H. Petit Institute for Bioengineering and Bioscience
  132. Peak Proteins
  133. Pelago Bioscience
  134. PEPperPRINT
  135. Polish Academy of Sciences
  136. Poochon Scientific
  137. Princeton University
  138. ProFI Proteomics
  139. Protagen Protein Services 
  140. Protea Biosciences
  141. Protein Metrics
  142. ProteinCT Biotechnologies
  143. Proteome Factory
  144. ProteomeTech
  145. Proteomics International
  146. Proteos
  147. ProtTech
  148. PTM Biolabs
  149. Radboud University
  150. Rajiv Gandhi Centre for Biotechnology 
  151. Research Center of CHU de Quebec Universite Laval
  152. Retrogenix
  153. Rockland Immunochemicals
  154. Rutgers New Jersey Medical School
  155. Saint Louis University
  156. Sandor LifeSciences
  157. SciGenom
  158. SciLifeLab
  159. Sciomics
  160. Scripps Research
  161. SGS
  162. Shanghai Applied Protein Technology 
  163. Shantani Proteome Analytics
  164. Smoler Proteomics Center
  165. SomaLogic
  166. Sanford Burnhum Prebys Medical Discovery Institute 
  167. Stratech Scientific
  168. Swiss Federal Institute of Technology Lausanne
  169. SYMBIOSIS
  170. System Biosciences 
  171. Tata Institute of Fundamental Research
  172. tebu-bio
  173. Temple University
  174. Texas A&M University
  175. The Institute of Plant Biochemistry and Photosynthesis 
  176. The National Institute for Cellular Biotechnology
  177. THE PROTEIN WORKS 
  178. The University of Tennessee Health Science Center
  179. The University of Texas Health Science Center at Houston
  180. The University of Texas System
  181. The Wistar Institute
  182. Thermo Fisher Scientific
  183. Translational Research Institute Australia
  184. Tymora Analytical Operations
  185. Ubiquigent
  186. UCLA Pasarow Mass Spectrometry Laboratory
  187. UCLA Proteome Research Center
  188. Universiti Sains Malaysia
  189. University of  Oklahoma
  190. University of Aberdeen
  191. University of Adelaide
  192. University of Bern
  193. University of Birmingham
  194. University of Bristol
  195. University of Calgary
  196. University of California, Davis
  197. University of California, Irvine School of Medicine
  198. University of Cambridge
  199. University of Cologne
  200. University of Dundee
  201. University of Edinburgh
  202. University of Florida Interdisciplinary Center for Biotechnology Research
  203. University of Gothenburg
  204. University of Heidelberg
  205. University of Helsinki
  206. University of Hong Kong
  207. University of Kentucky
  208. University of Lausanne 
  209. University of Leeds
  210. University of Leicester
  211. University of Manchester
  212. University of Maryland
  213. University of Massachusetts Boston
  214. University of Michigan Medical School
  215. University of Münster
  216. University of Nebraska-Lincoln
  217. University of North Carolina
  218. University of Oslo
  219. University of Oulu
  220. University of Oxford
  221. University of Pennsylvania 
  222. University of South Dakota
  223. University of South Florida
  224. University of Texas
  225. University of Texas Medical Branch
  226. University of Utah 
  227. University of Victoria Genome British Columbia Proteomics Centre
  228. University of Virginia
  229. University of Warwick
  230. University of Wisconsin-Madison
  231. University of York
  232. Upstate Medical University
  233. UT Southwestern Medical Center
  234. Vanderbilt University
  235. Vermont Genetics Network
  236. Virginia Commonwealth University
  237. vivoPharm
  238. VProteomics
  239. Wake Forest School of Medicine 
  240. Washington University
  241. Waters Corporation
  242. Yale School of Medicine
  243. Zyagen

Request Customization

Please select a suitable option for customization in the report

PRICING DETAILS

USD 4,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com